Tower Research Capital (TRC)’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

Tower Research Capital (TRC)’s Portfolio KBIO Stock Details KBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-300	Closed	-$3K	–	5835
2015 Q4	$3K	Sell	300 -130	-30%	-$1.44K	﹤0.01%	3663
2015 Q3	$1K	Buy	430 +48	+13%	+$127	﹤0.01%	3887
2015 Q2	$1K	Buy	+382	New	+$1.62K	﹤0.01%	4287
2014 Q4	–	Sell	-320	Closed	-$3K	–	5587
2014 Q3	$3K	Sell	320 -338	-51%	-$4.66K	﹤0.01%	3746
2014 Q2	$12K	Buy	658 +627	+2,023%	+$10.7K	﹤0.01%	2252
2014 Q1	$1K	Buy	+31	New	+$898	﹤0.01%	4381
2013 Q4	–	Sell	-110	Closed	-$4K	–	5564
2013 Q3	$4K	Buy	+110	New	+$5.01K	﹤0.01%	3909

Other funds holding KBIO

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Tower Research Capital (TRC)'s KBIO Position: Q1 2016 in Review

Tower Research Capital (TRC) sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2016, closing a stake of 300 shares — an estimated $3K sold.

Tower Research Capital (TRC) first reported a position in KBIO in Q3 2013 and held it in 7 quarters. The position peaked at $12K in Q2 2014. 1 fund tracked by Wall St. Rank holds KBIO as of Q1 2016.

Tower Research Capital (TRC) reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2016 after selling out during the quarter.
Tower Research Capital (TRC) sold 300 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2016, an estimated $3K.
Tower Research Capital (TRC) first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q3 2013 and held it in 7 quarters.
Tower Research Capital (TRC)'s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $12K in Q2 2014.
1 fund tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2016, filed 16 May 2016.